Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Meridian Bioscience, Inc. (NasdaqNM:VIVO)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider
Recent Events
Aug  9Dividend payment of $0.065
Location
3471 River Hills Drive
Cincinnati, OH 45244
Phone: (513) 271-3700
Fax: (513) 271-0124
Employees (last reported count): 369
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Related Links
 ·Search Yahoo! for related links...
Ownership
·Insider and 5%+ Owners: 36%
·Over the last 6 months:
 · 8 insider buys; 29.0K shares (0.6% of insider shares)
 · one insider sell; 2,000  shares
·Institutional: 24% (38% of float)
(34 institutions)
·Net Inst. Selling: 423.0K shares (+13.66%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Meridian Bioscience, Inc., formerly known as Meridian Diagnostics, Inc., is a fully integrated life sciences company that develops, manufactures and markets a broad range of disposable diagnostic test kits and related diagnostic products used for the rapid diagnosis of infectious diseases, and also offers biopharmaceutical capabilities. Meridian's diagnostics products provide accuracy, simplicity, and speed, and enable early diagnosis and treatment of common medical conditions such as gastrointestinal, viral, urinary tract and respiratory infections. In addition to the diagnostic business, through recent acquisitions Meridian has the ability to enable research efforts of genomics scientists in drug and vaccine development.
More from Market Guide: Expanded Business Description

Financial Summary
VIVO develops, manufactures and markets a broad range of disposable diagnostic test kits and related diagnostic products used for the rapid diagnosis of infectious diseases, and also offers biopharmaceutical capabilities. For the nine months ended 6/30/01, net sales fell 1% to $43 million. Net loss totaled $10.4 million, vs. income of $5.2 million. Results reflect the suspension of manufacturing of 30 products, and $11.2 million in impairment charges.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

William Motto, 59
Chairman, CEO
$519K--  
John Kraeutler, 52
Pres, COO, Director
387K--  
Richard Eberly, 39
Exec. VP of Sales and Marketing and Operations
249K--  
Antonio Interno, 50
Sr. VP
249K$1.0M
Larry Baldini, 41
VP-Operations
--  --  
Dollar amounts are as of 30-Sep-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:VIVOAs of 31-Aug-2001
Price and Volume
52-Week Low
on 30-Mar-2001
$2.125
Recent Price$5.40 
52-Week High
on 29-Sep-2000
$8.00 
Beta0.96 
Daily Volume (3-month avg)13.3K
Daily Volume (10-day avg)15.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-28.0%
52-Week Change
relative to S&P500
-3.4%
Share-Related Items
Market Capitalization$78.8M
Shares Outstanding14.6M
Float9.30M
Dividends & Splits
Annual Dividend (indicated)$0.26 
Dividend Yield4.82%
Last Split: 3 for 2 on 3-Oct-1995
Per-Share Data
Book Value (mrq)$1.61 
Earnings (ttm)-$0.59 
Earnings (mrq)-$0.04 
Sales (ttm)$3.89 
Cash (mrq)$0.22 
Valuation Ratios
Price/Book (mrq)3.35 
Price/EarningsN/A 
Price/Sales (ttm)1.39 
Income Statements
Sales (ttm)$56.9M
EBITDA (ttm)-$8.50M
Income available to common (ttm)-$8.54M
Profitability
Profit Margin (ttm)-15.0%
Operating Margin (ttm)-23.0%
Fiscal Year
Fiscal Year EndsSep 30
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-11.70%
Return on Equity (ttm)-28.84%
Financial Strength
Current Ratio (mrq)2.18 
Debt/Equity (mrq)1.37 
Total Cash (mrq)$3.22M
Short Interest
As of 8-Aug-2001
Shares Short11.0K
Percent of Float0.1%
Shares Short
(Prior Month)
10.0K
Short Ratio0.73 
Daily Volume15.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.